BRIEF published on 09/25/2025 at 20:21, 1 year ago ABIONYX Pharma : Résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie Plan France 2030 ABIONYX Pharma
BRIEF published on 09/25/2025 at 20:21, 1 year ago ABIONYX Pharma: Financial results for the first half of 2025 Financial Results Research And Development Treasury France 2030 Plan ABIONYX Pharma
PRESS RELEASE published on 09/25/2025 at 20:16, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats ABIONYX Pharma annonce ses résultats financiers du 1er semestre 2025. Chiffre d'affaires de 2,1 M€, pertes réduites. Trésorerie à 3,4 M€. Lauréat du plan France 2030 Chiffre D'affaires Résultats Financiers Trésorerie ABIONYX Pharma 1er Semestre 2025
PRESS RELEASE published on 09/25/2025 at 20:16, 1 year ago Inside Information / News release on accounts, results ABIONYX Pharma announces its 2025 half-year financial results, including revenue of €2.1 million and ongoing initiatives in biotech innovation. Company receives government support for sepsis research Revenue Biotech Innovation ABIONYX Pharma 2025 Financial Results Sepsis Research
PRESS RELEASE published on 09/25/2025 at 18:58, 1 year ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 08/28/2025 at 18:56, 1 year 1 month ago Bilan semestriel 2025 d'ABIONYX Pharma Chiffre D'affaires Trésorerie ABIONYX Pharma Soutien Financier Semestre 2025
BRIEF published on 08/28/2025 at 18:56, 1 year 1 month ago ABIONYX Pharma 2025 half-year review Treasury Financial Support Turnover ABIONYX Pharma Semester 2025
PRESS RELEASE published on 08/28/2025 at 18:51, 1 year 1 month ago Informations privilégiées / Autres communiqués ABIONYX Pharma fait le point sur son activité et sa trésorerie du 1er semestre 2025, notamment un chiffre d'affaires de 2,1 M€ provenant de sa filiale IRIS Pharma. La trésorerie s'établit à 3,4 M€ Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma Thérapies Innovantes
PRESS RELEASE published on 08/28/2025 at 18:51, 1 year 1 month ago Inside Information / Other news releases ABIONYX Pharma provided an update on its activity and cash position for Q2 2025. Company's revenue, cash position, and government funding details revealed Revenue Cash Position Update Government Funding ABIONYX Pharma
BRIEF published on 08/27/2025 at 19:31, 1 year 1 month ago ABIONYX Pharma en pourparlers pour un partenariat stratégique dans le sepsis Partenariat Stratégique ABIONYX Pharma Sepsis CER-001 Thérapies Innovantes
Published on 10/17/2026 at 03:20, 15 hours 3 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 15 hours 8 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 18 hours 48 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 18 hours 53 minutes ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 19 hours 23 minutes ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/17/2026 at 18:00, 22 minutes ago Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 5 hours 17 minutes ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 5 hours 32 minutes ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 22 hours 14 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 23 hours 2 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:54, 22 hours 28 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 23 hours 34 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 23 hours 34 minutes ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
